Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)

E. K. Akpek; K. Karadayl; J. K. Cheetham

doi:10.1016/S0002-9394(99)00333-5

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)

E. K. Akpek, K. Karadayl, J. K. Cheetham

School of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	662-663
Number of pages	2
Journal	American journal of ophthalmology
Volume	128
Issue number	5
DOIs	https://doi.org/10.1016/S0002-9394(99)00333-5
State	Published - 1999

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0002-9394(99)00333-5

Cite this

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters). / Akpek, E. K.; Karadayl, K.; Cheetham, J. K.
In: American journal of ophthalmology, Vol. 128, No. 5, 1999, p. 662-663.

Research output: Contribution to journal › Letter › peer-review

@article{238e7a3bf89a44cc9ba23c29ce447b30,

title = "Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)",

author = "Akpek, {E. K.} and K. Karadayl and Cheetham, {J. K.}",

year = "1999",

doi = "10.1016/S0002-9394(99)00333-5",

language = "English (US)",

volume = "128",

pages = "662--663",

journal = "American journal of ophthalmology",

issn = "0002-9394",

publisher = "Elsevier USA",

number = "5",

}

TY - JOUR

T1 - Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery

T2 - A randomized, vehicle-controlled clinical trial [2] (multiple letters)

AU - Akpek, E. K.

AU - Karadayl, K.

AU - Cheetham, J. K.

PY - 1999

Y1 - 1999

UR - http://www.scopus.com/inward/record.url?scp=0032705209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032705209&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(99)00333-5

DO - 10.1016/S0002-9394(99)00333-5

M3 - Letter

C2 - 10577550

AN - SCOPUS:0032705209

SN - 0002-9394

VL - 128

SP - 662

EP - 663

JO - American journal of ophthalmology

JF - American journal of ophthalmology

IS - 5

ER -

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this